Surrozen, Inc. (SRZN)
$24.76-16.60%Close
BUYCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $185M
- Beta
- 0.56
- P/E (TTM)
- -0.64
- Short % float
- 66.89%
- Days to cover
- 1.5
- SI change
- -0.3%
- 1W
- -15.00%
- 1M
- +30.32%
- vs SPY 1W
- -15.42%
- vs SPY 1M
- +28.26%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on SRZN?
- LOPJLB’s latest quantitative signal on Surrozen, Inc. (SRZN) is BUY in a CRISIS regime. Signals are updated daily.
- What market regime is SRZN in?
- Surrozen, Inc. (SRZN) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Surrozen, Inc. (SRZN) do?
- Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system. The company develops SZN-814, which …